QLS32015, a novel humanized IgG1 T-cell retargeting bispecific antibody, targets both GPRC5D, a G protein-coupled receptor class C group 5 member D, and CD3. By bridging CD3-expressing T cells and ...

Tecvayli (teclistamab) is an off-the-shelf bispecific antibody targeting both BCMA and CD3 which is also under ... antibody which is used to treat EGFR-mutated non-small cell lung cancer (NSCLC).

Atmosfera Restaurant and pizzeria Swindon menu Amgen/BeiGene's CD3/CLDN18.2 bispecific antibody has been submitted for cl ...

Johnson & Johnson's much-touted crop of bispecific ... approved to treat EGFR-mutated non-small cell lung cancer (NSCLC). The new double-headed antibody targets both CD3 and BCMA, a target that ...

QLS32015, a novel humanized IgG1 T-cell retargeting bispecific antibody, targets both GPRC5D, a G protein-coupled receptor class C group 5 member D, and CD3. By bridging CD3-expressing T cells and ...